(Q39585060)

13 September 2017

title

Hepatitis C virus and HIV antibodies in patients with hepatocellular carcinoma in Zimbabwe: a pilot study (English)

1 reference

13 September 2017

0 references

1 reference

hepatocellular carcinoma

1 reference

M Weinig

1

1 reference

13 September 2017

J G Hakim

series ordinal

2

1 reference

13 September 2017

I Gudza

series ordinal

3

1 reference

13 September 2017

O Tobaiwa

series ordinal

4

1 reference

13 September 2017

publication date

1 September 1997

1 reference

Transactions of the Royal Society of Tropical Medicine and Hygiene

13 September 2017

published in

1 reference

13 September 2017

volume

91

1 reference

13 September 2017

issue

5

1 reference

13 September 2017

page(s)

570-572

1 reference

Absence of a relationship between antibodies to hepatitis C virus and hepatocellular carcinoma in Mozambique

13 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2897%2990029-8

7 January 2021

Detection of hepatitis C viraemia in Caucasian patients with hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2897%2990029-8

7 January 2021

Changes in the prevalence of hepatitis B and C infection in patients with hepatocellular carcinoma in the Nagasaki Prefecture, Japan

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2897%2990029-8

7 January 2021

Hepatitis C virus and hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2897%2990029-8

7 January 2021

Hepatitis C virus antibodies in southern African blacks with hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2897%2990029-8

7 January 2021

Hepatitis C virus infection as a risk factor for hepatocellular carcinoma in patients with cirrhosis. A case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2897%2990029-8

7 January 2021

Hepatitis C virus antibody in patients with primary liver cancer (hepatocellular carcinoma, cholangiocarcinoma, and combined hepatocellular-cholangiocarcinoma) in Japan

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2897%2990029-8

7 January 2021

The interrelationship between HBV‐markers and HIV antibodies in patients with hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2897%2990029-8

7 January 2021

Prevalence of hepatitis B and C viral markers in black and white patients with hepatocellular carcinoma in the United States.

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2897%2990029-8

7 January 2021

10.1016/S0035-9203(97)90029-8

Identifiers

DOI

1 reference

release_j4py6t3exnazdl6cdll7sjl2gy

13 September 2017

Fatcat ID

0 references

1 reference